Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spannagl

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 15, 2012
Prospective, non-interventional study on the real-world use of certoparin in daily practice--the PROMEMBER studyMichael Spannagl, Nima Melzer, Peter Bramlage, et al.
Critical Care (London, England)|February 25, 2011
Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicityBenny Sørensen, Donat R Spahn, Petra Innerhofer, et al.
Anesthesia and Analgesia|January 1, 2010
A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgeryChristian F Weber, Wulf Dietrich, Michael Spannagl, et al.
Platelets|January 11, 2021
A novel approach to laboratory assessment and reporting of platelet von Willebrand factorThorsten Kragh, Isabell Pekrul, Helmut W Ott, et al.
British Journal of Haematology|December 21, 2004
Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individualsMichael Schleef, Erwin Strobel, Andrea Dick, et al.
Thrombosis and Haemostasis|June 17, 2019
Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia AJens Müller, Isabell Pekrul, Bernd Pötzsch, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 14, 2019
Emicizumab in the Treatment of Acquired Haemophilia: A Case ReportPatrick Möhnle, Isabell Pekrul, Michael Spannagl, et al.
American Journal of Clinical Pathology|August 15, 2008
Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitorsAndreas Calatzis, Dirk Peetz, Sylvia Haas, et al.
Anesthesia and Analgesia|February 15, 2013
The influence of antithrombin substitution on heparin sensitivity and activation of hemostasis during coronary artery bypass graft surgery: a dose-finding studyWulf Dietrich, Raimund Busley, Michael Spannagl, et al.
Deutsches Arzteblatt International|September 27, 2013
The perioperative management of treatment with anticoagulants and platelet aggregation inhibitorsAxel Schlitt, Csilla Jámbor, Michael Spannagl, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 15, 2012
Prospective, non-interventional study on the real-world use of certoparin in daily practice--the PROMEMBER studyMichael Spannagl, Nima Melzer, Peter Bramlage, et al.
Critical Care (London, England)|February 25, 2011
Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicityBenny Sørensen, Donat R Spahn, Petra Innerhofer, et al.
Anesthesia and Analgesia|January 1, 2010
A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgeryChristian F Weber, Wulf Dietrich, Michael Spannagl, et al.
Platelets|January 11, 2021
A novel approach to laboratory assessment and reporting of platelet von Willebrand factorThorsten Kragh, Isabell Pekrul, Helmut W Ott, et al.
British Journal of Haematology|December 21, 2004
Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individualsMichael Schleef, Erwin Strobel, Andrea Dick, et al.
Thrombosis and Haemostasis|June 17, 2019
Laboratory Monitoring in Emicizumab-Treated Persons with Hemophilia AJens Müller, Isabell Pekrul, Bernd Pötzsch, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 14, 2019
Emicizumab in the Treatment of Acquired Haemophilia: A Case ReportPatrick Möhnle, Isabell Pekrul, Michael Spannagl, et al.
American Journal of Clinical Pathology|August 15, 2008
Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitorsAndreas Calatzis, Dirk Peetz, Sylvia Haas, et al.
Anesthesia and Analgesia|February 15, 2013
The influence of antithrombin substitution on heparin sensitivity and activation of hemostasis during coronary artery bypass graft surgery: a dose-finding studyWulf Dietrich, Raimund Busley, Michael Spannagl, et al.
Deutsches Arzteblatt International|September 27, 2013
The perioperative management of treatment with anticoagulants and platelet aggregation inhibitorsAxel Schlitt, Csilla Jámbor, Michael Spannagl, et al.
Pageof 11